Abstract
These recommendations for quality improvement of cystic fibrosis genetic diagnostic testing provide general guidelines for the molecular genetic testing of cystic fibrosis in patients/individuals. General strategies for testing as well as guidelines for laboratory procedures, internal and external quality assurance, and for reporting the results, including the requirements of minimal services in mutation testing, the nomenclature for describing mutations, procedures to control false-positive amplification reactions and to validate tests, and guidelines to implement a quality system in a molecular diagnostic laboratory are reviewed.
Publication types
-
Guideline
-
Practice Guideline
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Accreditation
-
Adolescent
-
Adult
-
Child
-
Cystic Fibrosis / diagnosis*
-
Cystic Fibrosis / genetics*
-
Cystic Fibrosis / physiopathology
-
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
-
Databases as Topic
-
Europe
-
False Positive Reactions
-
Gene Frequency
-
Genetic Counseling / methods
-
Genetic Predisposition to Disease
-
Genetic Testing / methods*
-
Humans
-
Infertility / genetics
-
Mutation / genetics
-
Polymorphism, Genetic
-
Prenatal Diagnosis / methods
-
Quality Control
-
Reagent Kits, Diagnostic
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Specimen Handling
-
Sweat
-
Terminology as Topic
Substances
-
CFTR protein, human
-
Reagent Kits, Diagnostic
-
Cystic Fibrosis Transmembrane Conductance Regulator